Treating Superficial Venous Thrombophlebitis

Superficial venous thrombophlebitis (SVT) is characterized as a localized inflammatory condition of the venous vessels underlying the skin. It arises from thrombosis of a superficial vein, and clinical presentation usually involves pain, erythema, and tenderness at the sites of inflammation. Although the condition is usually self-limited and not serious or fatal, symptomatic superficial thrombophlebitis can be debilitating, limit movement and certain capabilities, or progress to involve the deep venous system and cause pulmonary embolism. SVT is typically associated with venous valvular insufficiency, pregnancy, infection, and prothrombotic conditions, including malignancy. Currently, medical therapies comprising bedrest, elastic stockings, compression bandages, nonsteroidal anti-inflammatory drugs, and low molecular weight heparins are used to reduce the extension of inflammation and recurrence of thrombotic events in patients experiencing SVT. In patients refractory to conservative measures, surgical interventions such as phlebectomy, sclerotherapy, saphenous junction ligation, or saphenous vein stripping are potential treatments.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Jason T. Lee, MD, Division of Vascular Surgery, 300 Pasteur Drive, Suite H3600, Stanford, CA 94305. E-mail: jtlee@stanford.edu
  • 1.

    Luis Rodriguez-Peralto J, Carrillo R, Rosales B, Rodriguez-Gil Y. Superficial thrombophlebitis. Semin Cutan Med Surg 2007;26:7176.

  • 2.

    Ascher E, Hanson JN, Salles-Cunha S, Hingorani A. Lesser saphenous vein thrombophlebitis: its natural history and implications for management. Vasc Endovascular Surg 2003;37:421427.

    • Search Google Scholar
    • Export Citation
  • 3.

    Skillman J. Superficial phlebitis: inflammatory, infectious associated with deep vein thrombosis. New York: WB Saunders; 2001.

  • 4.

    Samlaska CP, James WD. Superficial thrombophlebitis. II. Secondary hypercoagulable states. J Am Acad Dermatol 1990;23:118.

  • 5.

    Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998;158:151156.

    • Search Google Scholar
    • Export Citation
  • 6.

    Brook I, Frazier EH. Aerobic and anaerobic microbiology of superficial suppurative thrombophlebitis. Arch Surg 1996;131:9597.

  • 7.

    Sproul EE. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938;34:566585.

    • Search Google Scholar
    • Export Citation
  • 8.

    Wester JP, Kuenen BC, Menwissen OJ. Mondor's disease as the first thrombotic event in hereditary protein C deficiency and anticardiolipin antibodies. Neth J Med 1997;50:8587.

    • Search Google Scholar
    • Export Citation
  • 9.

    Martinelli I, Cattaneo M, Taioli E. Genetic risk factors for superficial vein thrombosis. Thromb Haemost 1999;82:12151217.

  • 10.

    de Godoy JM, Batigalia F, Braile DM. Superficial thrombophlebitis and anticardiolipin antibodies—report of association. Angiology 2001;52:127129.

    • Search Google Scholar
    • Export Citation
  • 11.

    Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 1991;114:845854.

    • Search Google Scholar
    • Export Citation
  • 12.

    O'Grady NP, Alexander M, Dellinger EP. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-10):129.

    • Search Google Scholar
    • Export Citation
  • 13.

    Leon L, Giannoukas AD, Dodd D. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005;29:1017.

  • 14.

    Lutter KS, Kerr TM, Roederscheimer LR. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery 1991;110:4246.

  • 15.

    Sullivan V, Denk PM, Sonnad SS. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system. J Am Coll Surg 2001;193:556562.

    • Search Google Scholar
    • Export Citation
  • 16.

    Quenet S, Laporte S, Decousus H. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. J Vasc Surg 2003;38:944949.

    • Search Google Scholar
    • Export Citation
  • 17.

    Belcaro GG, Nicolaides AA, Errichi BB. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999;50:523529.

    • Search Google Scholar
    • Export Citation
  • 18.

    Buller HR, Agnelli G, Hull RD. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):401S428S.

    • Search Google Scholar
    • Export Citation
  • 19.

    Michaels JA, Brazier JE, Campbell WB. Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins. Br J Surg 2006;93:175181.

    • Search Google Scholar
    • Export Citation
  • 20.

    Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Eendovascular Surg 2003;37:415420.

    • Search Google Scholar
    • Export Citation
  • 21.

    Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162164.

  • 22.

    Darke SG, Baker SJ. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins. Br J Surg 2006;93:969974.

All Time Past Year Past 30 Days
Abstract Views 2 0 0
Full Text Views 223 148 4
PDF Downloads 93 79 6
EPUB Downloads 0 0 0